A challenge in medical genomics is to identify variants and genes associated with severe genetic disorders. Based on the premise that severe, early-onset disorders often result in a reduction of evolutionary fitness, several statistical methods have been developed to predict pathogenic variants or constrained genes based on the signatures of negative selection in human populations. However, we currently lack a statistical framework to jointly predict deleterious variants and constrained genes from both variant-level features and gene-level selective constraints. Here we present such a unified approach, UNEECON, based on deep learning and population genetics. UNEECON treats the contributions of variant-level features and gene-level constraints as a variant-level fixed effect and a gene-level random effect, respectively. The sum of the fixed and random effects is then combined with an evolutionary model to infer the strength of negative selection at both variant and gene levels. Compared with previously published methods, UNEECON shows unmatched performance in predicting missense variants and protein-coding genes associated with autosomal dominant disorders, and feature importance analysis suggests that both gene-level selective constraints and variant-level predictors are important for accurate variant prioritization. Furthermore, based on UNEECON, we observe an unexpected low correlation between gene-level intolerance to missense mutations and that to loss-of-function mutations, which can be partially explained by the prevalence of disordered protein regions that are highly tolerant to missense mutations. Finally, we show that genes intolerant to both missense and loss-of-function mutations play key roles in the central nervous system and the autism spectrum disorders. Overall, UNEECON is a promising framework for both variant and gene prioritization.
loss-of-function mutations. In addition, we find that genes under strong selective constraints at both missense and loss-of-function levels are strongly associated with the central nervous system and the autism spectrum disorders, highlighting the need to investigate the function of these highly constrained genes in future studies. able to distinguish pathogenic missense variants from proximal benign missense variants. 47 Since variant-level and gene-level prioritization methods leverage complementary occurrence probability of missense mutation i in the gnomAD exome sequencing data. 105
Variant-level features of mutation i in gene j Overview of the UNEECON model. UNEECON estimates negative selection on missense mutation i in gene j based on the relative probability of the occurrence of the missense mutation, η ij , compared to the occurrence probability of neutral mutations, µ ij . η ij depends on the sum of a variant-level fixed effect, z ij , and a gene-level random effect, u j . We assume that z ij captures the contribution of variant-level features, X ij , to negative selection, and model the relationship between X ij and z ij with a feedforward neural network. We assume that u j is a Gaussian random variant modeling the gene-level variation of selective constraints that cannot be predicted from variant features. The sum of z ij and u j is then sent to a logistic function to obtain η ij . The neutral occurrence probability, µ ij , is from a context-dependent mutation model trained on putatively neutral mutations. Free parameters of the UNEECON model are estimated by minimizing the discrepancy between the predicted occurrence probability, η ij · µ ij , and the observed occurrence of each potential missense mutation in the gnomAD exome sequencing data [29] .
We estimate the parameters of the UNEECON model by minimizing the discrepancy 106 between the predicted occurrence probability, η ij · µ ij , and the observed Distributions of UNEECON scores across potential missense mutations. (a) Distributions of UNEECON scores estimated for potential missense mutations in haploinsufficient (HI) genes [37] , autosomal dominant disease genes [35, 36] , autosomal recessive disease genes [35, 36] , and olfactory receptor genes [45] . (b) Distributions of UNEECON scores estimated for potential missense mutations in various protein regions. The functional sites and protein secondary structures are based on UniProt annotations [47] . The predicted disordered protein regions are from MobiDB [48] . (c) Average UNEECON scores estimated for all codon positions in the CDKL5 protein. Each grey dot represents the UNEECON score averaged over all missense mutations in a codon position. Blue curve represents the locally estimated scatterplot smoothing (LOESS) fit. Blue and red dots represent pathogenic and benign missense variants from ClinVar [30] , respectively. The horizontal line represents a constrained region reported in a previous study [25] .
are also present in gnomAD. Then, we matched the numbers of positives and negatives 165 by random sampling without replacement. 166 Overall, UNEECON outperformed previous methods in predicting ClinVar missense 167 variants associated with autosomal dominant disorders ( Fig. 3a ; Table S2 ). Among the 168 previously published methods, variant-level predictors performed better than gene-level 169 and region-level constraint scores. To test the robustness of these results, we 170 constructed an alternative set of dominant pathogenic variants defined as all the 171 pathogenic missense variants located in 709 genes associated with autosomal dominant 172 diseases [35, 36] . UNEECON again outperformed the other methods in this dataset, 173 even though the difference of performance between UNEECON and LASSIE was not 174 October 15, 2019 6/23 statistically significant ( Fig. S2 ; Table S2 ). in ClinVar [30] . As expected, UNEECON was outperformed by multiple methods, such 180 as LASSIE [12] and Eigen [50] , in this setting ( Fig. S3 ). Similar results were reached 181 with an alternative set of recessive pathogenic variants defined as all the pathogenic 182 missense variants located in 1,183 autosomal recessive genes [35, 36] (Fig. S4 ).
183
As an orthogonal benchmark of UNEECON's performance in predicting dominant 184 disease variants, we investigated whether UNEECON was able to predict de novo 185 missense mutations identified in individuals affected by severe developmental 186 disorders [31] . We obtained de novo missense variants identified in affected individuals 187 and healthy individuals from denovo-db [51] . Then, for multiple percentile rank cutoff 188 values (top 10%, 20%, 30%, and 40%), we evaluated the enrichment of deleterious 189 variants predicted by each method in the affected individuals. Overall, missense variants 190 predicted by UNEECON and MPC showed the highest enrichments in the affected 191 October 15, 2019 7/23 individuals ( Fig. 3b ), suggesting that these two methods were more powerful in 192 predicting de novo risk mutations. The performance gaps between UNEECON/MPC 193 and the other methods were highest at the most stringent cutoff of 10% ( Fig. 3b ).
194
UNEECON-G scores perform favorably in predicting disease 195 genes and essential genes 196
The UNEECON model also provided UNEECON-G scores which measure gene-level 197 intolerance to missense mutations. We compared the performance of UNEECON-G 198 scores with alternative gene constraint scores, including RVIS [16] , pLI [17] , mis-z [17] , 199 and GDI [19] , in the setting of predicting disease genes and essential genes. The disease 200 gene sets included 709 autosomal dominant disease genes [35, 36] and 294 201 haploinsufficient genes [37] . The essential gene sets included 2,454 human orthologs of 202 mouse essential genes [33, 34] and 683 human essential genes identified by CRISPR 203 knockout experiments in human cell lines [32] . For each set of autosomal dominant 204 disease genes, haploinsufficient genes, and mouse essential genes, we constructed a 205 negative gene set by sampling a matched number of genes from the other genes in the 206 human genome. For the essential genes identified by CRISPR in cell lines, we 207 constructed a negative gene set by sampling a matched number of genes from the 208 nonessential genes reported in the same study [32] . Overall, UNEECON-G significantly 209 outperformed alternative gene-level metrics in predicting the four sets of essential and 210 disease genes ( Fig. 4 ; Table S3 ). In the linear surrogate model, the relative probability of the occurrence of mutation 227 i in gene j, η ij , is a linear combination of variant features, X ij , and the gene-level 228 random effect, u j , up to a logistic transformation. Analogous to the interpretation of 229 canonical linear models, we defined the contribution score of a variant feature as the 230 negative value of the weight (regression coefficient) associated with this feature, and 231 similarly defined the contribution score of the gene-level random effect as the negative 232 value of its standard deviation. Positive and negative contribution scores suggest that Predictive power of various methods for distinguishing disease and essential genes from genes not likely to have strong phenotypic effects. (a) Performance in predicting autosomal dominant disease genes [35, 36] . (b) Performance in predicting haploinsufficient genes [37] . (c) Performance in predicting human orthologs of mouse essential genes [33, 34] . (d) Performance in predicting human essential genes in cell lines [32] . True positive and true negative rates correspond to the fractions of positive and negative genes exceeding various thresholds, respectively. AUC corresponds to the area under the receiver operating characteristic curve.
predictions from LRT, PROVEAN, and SIFT, and a subset of protein structural The UNEECON-G score represents gene-level intolerance to missense mutations in 249 human populations. Alternatively, selective constraint on a gene can be defined as its 250 degree of intolerance to loss-of-function mutations, such as stop-gained, frameshift, and 251 splice-site mutations [17, 28, 29] . We investigated the correlation between the 252 UNEECON-G score and the pLI score, a metric of gene-level intolerance to 253 loss-of-function mutations [17] . Surprisingly, the UNEECON-G score was only 254 moderately correlated with the pLI score (Spearman's ρ = 0.59; Fig. 5a ), suggesting a 255
October 15, 2019 9/23 discrepancy between gene-level intolerance to missense mutations and that to 256 loss-of-function mutations in a subset of protein-coding genes. Intrinsically disordered proteins play key roles in a multitude of biological 258 processes [52] , but their sequences are poorly conserved across species [53] . Therefore, 259 missense mutations in intrinsically disordered proteins may be under weak negative 260 selection even if loss-of-function mutations in these proteins are deleterious. To test this 261 hypothesis, we investigated the distributions of protein disorder content, i.e., the 262 fraction of disordered regions in a protein [48] , across 1,912 protein-coding genes 263 intolerant to heterozygous loss-of-function mutations (pLI score ≥ 0.9). We split the 264 1,912 genes into two equal-size groups based on their UNEECON-G scores, and defined 265 the 956 genes with higher UNEECON-G scores as the gene set intolerant to both missense and loss-of-function mutations. Accordingly, we defined the 956 genes with 267 lower UNEECON-G scores as the gene set tolerant to missense but not to 268 loss-of-function mutations. Compared with the 956 genes intolerant to both missense 269 and loss-of-function mutations, the disorder contents were significantly higher in the 956 270 genes tolerant to missense mutations but not to loss-of-function mutations (Fig. 5b ).
271
Therefore, disordered protein regions can at least partially explain the observed 272 discrepancy between missense constraints and loss-of-function constraints. 273 We further investigated the enrichment of Reactome pathways [54] and Gene
274
Ontology terms [55, 56] in the 956 genes intolerant to both missense and loss-of-function 275 mutations, using the 956 genes tolerant to missense but not to loss-of-function 276 mutations as a background. Several key pathways associated with central nervous 277 system, gene regulation, cell cycle, and innate immune response were overrepresented in 278 the genes intolerant to both missense and loss-of-function mutations ( Fig. 5c ; Table S4 ). 279 We observed an enrichment of similar terms based on the Gene Ontology (Table S5 & 280 S6). In agreement with the enrichment of pathways associated with the central nervous 281 system, the genes intolerant to both missense and loss-of-function mutations were 282 strongly enriched in the gene set implicated in the autism spectrum disorders [57] 283 ( Fig. 5d ). UNEECON is unlikely to suffer from the circularity and the inflated performance 294 commonly found in supervised methods [58] .
295
It is worth noting that UNEECON is different from existing prioritization methods 296 in multiple important aspects. First, unlike classical sequence conservation 297 metrics [38] [39] [40] [41] [42] and integrative variant scores [8] [9] [10] [11] [12] [13] [14] [15] , UNEECON infers the strength of 298 negative selection based on rare genetic variants. Therefore, UNEECON predicts 299 strongly deleterious variants with a dominant/semidominant mode of inheritance [59] . 300 Second, unlike previously published gene constraint metrics that typically assign the 301 same score to all missense variants within a gene [16] [17] [18] [19] [20] [21] [22] [23] , UNEECON assigns different 302 scores to the variants in the same gene in a feature-dependent manner, providing 303 high-resolution maps of variant effects within genes. Third, UNEECON is able to adjust 304 the distribution of variant scores within a gene according to the degree of depletion of 305 missense variants in this gene, allowing for assigning different scores to missense 306 mutations with similar variant features but located in different genes.
307
Similar to other metrics of negative selection, the performance of UNEECON 308 strongly depends on the correlation between variant penetrance and negative selection. 309 Our analysis of pathogenic variants suggests that UNEECON can predict deleterious 310 variants associated with dominant genetic disorders but not necessarily those associated 311 with recessive disorders. Also, because common variants are unlikely to be under strong 312 negative selection [12] , UNEECON scores might not be able to predict common variants 313 associated with complex traits or late-onset diseases. In contrast, a recent study 314 suggests that rare variants associated with complex traits are strongly enriched in 315 coding regions and tend to be under negative selection [60] fraction of the variation of negative selection across missense variants. We expect that 324 the combination of variant-level predictors and gene-level constraints will be an essential 325 component in the future development of variant and gene prioritization methods.
326
By contrasting UNEECON-G scores against pLI scores, we observe an unexpected 327 low correlation between gene-level intolerance to missense mutations and that to 328 loss-of-function mutations. The prevalence of disordered protein regions in the human 329 proteome is a key biological factor contributing to the low correlation between missense 330 and loss-of-function constraints. Furthermore, we observe that the genes intolerant to 331 both loss-of-function mutations and missense mutations may play key roles in the 332 HMMEntropy [67] , and phyloP scores [40] . The protein structural features included 345 predicted secondary structures, B-factors, contributions to protein stability, and relative 346 solvent accessibilities from SNVBox [67] . The functional genomic features included the 347 non-commercial version of SPIDEX splicing scores [68] and the maximum RNA-seq 348 signals from the Roadmap Epigenomics Project [69] . Following a common practice in 349 machine learning and statistics, we standardized continuous features by subtracting the 350 mean and dividing by the standard deviation. All the features were based on the hg19 351 (GRCh37) assembly.
352
Population genomic data 353 We dowloaded whole genome variation data, exome variation data, and corresponding 354 sequencing coverage data from the gnomAD browser [28, 29] (version 2.1.0). We only 355 retained rare SNVs (MAF < 0.1%) that passed gnomAD's built-in quality filter for 356 downstream analysis.
357
Context-dependent mutation model 358 We trained a context-dependent mutation model to capture the impact of 7-mer 359 sequence context, local mutation rate, and sequencing coverage on the probability of the 360 occurrence of each mutation in the gnomAD exome sequencing data. Because of the intrinsic sparsity of putatively neutral variants in coding regions, it is difficult to build a 362 mutation model solely based on the gnomAD exome sequencing data. Therefore, we 363 first built a mutation model based on neutral noncoding variants in the gnomAD whole 364 genome sequencing (WGS) data. Then, we recalibrated the WGS-based mutation model 365 in the gnomAD exome sequencing data to adjust for the differences in population 366 sample size and sequencing coverage between the WGS and the exome sequencing data. 367 To build the WGS-based mutation model, we first compiled a list of putatively 368 neutral noncoding regions following a strategy described in previous studies [10, 70, 71] . 369 We removed coding exons [72] , conserved phastCons elements [73] , nucleotide sites 370 within 1000 bp of any coding exons, and nucleotide sites within 100 bp of any phastCons 371 elements. We assumed that the remaining noncoding regions were largely depleted with 372 functional elements and, therefore, mutations in these regions were putatively neutral. 373 It is worth noting that we also removed any nucleotide sites with an average sequencing 374 coverage below 20, due to the difficulty of variant calling in low coverage regions, and 375 any sites overlapping CpGs, due to the high mutation rates in these sites.
376
Then, we fit a WGS-based mutation model to the gnomAD WGS data in putatively 377 neutral noncoding regions. First, for each possible combination of mutation l and 378 sequence context k (the focal nucleotide with 3 flanking nucleotides on each side), we 379 calculated its mutability, f k→l , defined as the proportion of 7-mer sequences of k with 380 observed rare variant l in the gnomAD WGS data. We defined 381 F k→l = logit(f k→l ) ≡ log( f k→l 1−f k→l ), which represents the contribution of sequence 382 context and mutation type to the probability of variant occurrence in logit scale.
383
Second, we fit a genome-wide logistic regression model to estimate the contributions of 384 sequencing depth and context-dependent mutability to the probability of the occurrence 385 of a mutation. This logistic regression model assumed
where Y WGS i is a binary indicator of the occurrence of neutral noncoding mutation i in 387 the gnomAD WGS data. d i is the average sequencing depth at the nucleotide position 388 of mutation i. k i and l i are the sequence context and the mutation type of mutation i, 389 respectively. We then fit a local logistic regression model for each exon m in the human 390 genome with 391 logit(Y WGS i ) = α m 3 +α 1 log(d i ) +α 2 F ki→li , for all mutation i s within 60 kb of exon m
where α m 3 is an exon specific intercept independently estimated for each exon m, andα 1 392 andα 2 are the estimates of regression coefficients in Eq. 1. The local regression model 393 effectively added an exon-specific, multiplicative scaling factor to adjust for the 394 variation of local mutation rates across exons. We defined
as the logit of the occurrence probability of mutation i in exon m in the WGS-based 396 mutation model.
397
Finally, we recalibrated the WGS-based mutation model in the gnomAD exome 
where Y exome i is a binary indicator of the presence of synonymous mutation i in the 400 gnomAD exome sequencing data. The exome-based logistic regression model effectively 401 added a multiplicative scaling factor to accommodate for the differences in population 402 sample size and sequencing coverage between the WGS and the exome sequencing data. 403 In the final exome mutation model, we defined the probability of the occurrence of 404 missense mutation i in gene j as 405 µ ij = logistic(β 0 + q i ) ≡ exp(β 0 + q i ) 1 + exp(β 0 + q i ) ,
whereβ 0 is the maximum likelihood estimate of β 0 in Eq. 4. We fit all the logistic 406 regression models using the glm function in R [74] .
407
Details of the UNEECON model 408 We assume that negative selection on a potential mutation is a mathematical function 409 of the sum of a variant-level fixed effect, z ij , and a gene-level random effect, u j (Fig. 1) . 410 Denoting X ij as the vector of variant features associated with mutation i in gene j, we 411 assume that the variant-level fixed effect, z ij , can be modeled by a feedforward neural 412 network. At the bottom of the neural network, a nonlinear hidden layer and a dropout 413 layer are employed to transform X ij to a hidden vector,
414
H ij = droput(ReLU(X ij · W hidden + B hidden )),
where ReLU and dropout are the rectified linear layer [75] and the dropout layer [43] , 415 respectively. W hidden and B hidden are the weight matrix and bias vector of the hidden 416 layer, respectively. Then, we assume the fixed effect term, z ij , is a linear combination of 417 the hidden vector H ij ,
where W output and b output are the weight vector and the bias term, respectively. We use 419 the Glorot method [76] to initialize the weights, W hidden and W output , and initialize the 420 bias terms, B hidden and b output , with zeros. In the dropout layer, we use a fixed dropout 421 rate of 0.5. It is worth noting that, if a linear version of the UNEECON model is used, 422 Eq. 6 will be replaced by an identity function H ij ≡ X ij .
423
To capture the variation of gene-level selective constraints that cannot be predicted 424 from feature vector X ij , we introduce a gene-level random-effect term following a 425 Gaussian distribution, 426 u j ∼ N (0, σ),
where σ is the standard deviation of the Gaussian distribution. Given the fixed and 427 random effect terms, we assume η ij , the relative probability of the occurrence of 428 mutation i in gene j, follows 429 η ij = logistic(z ij + u j ) ≡ exp(z ij + u j ) 1 + exp(z ij + u j )
.
We further assume that the total probability of the occurrence of potential missense 430 mutation i in gene j is equal to the product of η ij and µ ij , the probability of variant 431 occurrence under the neutral mutation model described in Eq. 5. Accordingly, the 432 likelihood function for the data associated with gene j is defined as
where Y ij is a binary indicator of the occurrence of missense mutation i in gene j in the 434 gnomAD exome sequencing data.
